Blyners Pharmaceuticals Private Limited
Blyners Pharmaceuticals Private Limited is a Private Non-govt company company incorporated in 2018 and based in Maharashtra, India. It was founded by Rajendra and Yogesh. Blyners Pharmaceuticals Private Limited operates in Pharmaceuticals & Chemicals (NIC 24290) with authorized capital of ₹1.00 L and paid-up capital of ₹1.00 L. For 2021-22, the company reported revenue of ₹92.80 L and a net loss of ₹21.56 L. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
BLYNERS PHARMACEUTICALS PRIVATE LIMITED is the legal entity of Blynerspharma.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Blyners Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +26d | filed |
| MGT-7 | FY2024-25 | 20 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +25d | filed |
| MGT-7 | FY2023-24 | 25 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 22 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Blyners Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 127984611 | HDFC Bank Ltd(Bank) | ₹6.05 Cr | 19 Sep 2020 | Satisfied |
| 852508582 | HDFC Bank Ltd(Bank) | ₹10.96 Cr | 19 Sep 2022 | Satisfied |
| 956166929 | ICICI Bank Ltd(Bank) | ₹24.57 Cr | 19 Sep 2021 | Open |
| 667167933 | ICICI Bank Ltd(Bank) | ₹5.66 Cr | 19 Sep 2020 | Open |
| 368857668 | HDFC Bank Ltd(Bank) | ₹4.29 Cr | 19 Sep 2023 | Open |
Charge IDs, lenders & amounts for Blyners Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2021-22 | — | ||||
| 2020-21 | — |
Detailed Financials
2 FYs| Line item | 2021-22 | 2020-21 |
|---|---|---|
| Income statement | ||
| Revenue from operations | ||
| Other income | ||
| Total income | ||
| Total expenses | ||
| Profit before tax | ||
| Profit / (Loss) after tax | ||
| Balance sheet | ||
| Equity / Net worth | ||
| Borrowings | ||
| Current liabilities | ||
| Total liabilities | ||
| Current assets | ||
| Cash & equivalents | ||
| Total assets | ||
| Employees | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2021-22 | +32.0% | — | — | |
| Profit after Tax2021-22 | -484.0% | — | — | |
| Net Worth2021-22 | -745.0% | — | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2020-21 | +7.77% | — | +139.66% | +9.97% | 14.01 | |||
| 2021-22 | -23.24% | +54.51% | — | -17.05% | — |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 4 | 2,63,01,454 | 82.41% |
| Institutional Investors | 2 | 21,35,458 | 6.69% |
| Public & Others | 15 | 34,78,748 | 10.90% |
Promoter, institutional & public holding for Blyners Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
388 peersEvents & timeline
3External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.